<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02163980</url>
  </required_header>
  <id_info>
    <org_study_id>4-2011-0111</org_study_id>
    <nct_id>NCT02163980</nct_id>
  </id_info>
  <brief_title>Effect of Dexmedetomidine on the Characteristics of High Volume/Low Concentration Ropivacaine in a Caudal Block in Pediatrics</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators perform this study to evaluate the effects of caudal Dexmedetomidine (DEX)
      added to high volume/low-concentration of ropivacaine in children undergoing orchiopexy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vital sign</measure>
    <time_frame>up to 180 min after surgery</time_frame>
    <description>systolic arterial pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>inhalation anesthetics requirements</measure>
    <time_frame>up to 180 min after surgery</time_frame>
    <description>end-tidal sevoflurane concentration required to maintain hemodynamic changes &lt; 20% of the preoperative baseline</description>
  </secondary_outcome>
  <other_outcome>
    <measure>incidence of agitation</measure>
    <time_frame>up to 180 min after surgery</time_frame>
    <description>number of patients</description>
  </other_outcome>
  <other_outcome>
    <measure>sedation score</measure>
    <time_frame>up to 180 min after surgery</time_frame>
    <description>three-point scale (0=eyes open spontaneously, 1=verbal stimulation, 2=physical stimulation</description>
  </other_outcome>
  <other_outcome>
    <measure>pain scores</measure>
    <time_frame>up to 180 min after surgery</time_frame>
    <description>Face Legs Activity Cry, Consolability scale (FLACC) Children's Hospital of Eastern Ontario Pain Scale (CHEOPS)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Ambulatory Orchipexy</condition>
  <arm_group>
    <arm_group_label>Caudal ropivacaine + normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1.5ml kg-1 ropivacaine 0.15% with normal saline (Control group, n=40).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caudal ropivacaine + dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.5ml kg-1 ropivacaine 0.15% with dexmedetomidine 1 Î¼g kg-1 (DEX group, n=40)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal ropivacaine + normal saline</intervention_name>
    <arm_group_label>Caudal ropivacaine + normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal ropivacaine + dexmedetomidine</intervention_name>
    <arm_group_label>Caudal ropivacaine + dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children undergoing ambulatory orchiopexy,

          -  ASA status I

        Exclusion Criteria:

          -  mental retardation,

          -  developmental delay,

          -  neurological or psychiatric illness,

          -  coagulation disorder,

          -  spinal anomalies
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yonsei Univ. College of Medicine Dep. Of Anesthesiology</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2014</study_first_submitted>
  <study_first_submitted_qc>June 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2014</study_first_posted>
  <last_update_submitted>June 13, 2014</last_update_submitted>
  <last_update_submitted_qc>June 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>caudal block</keyword>
  <keyword>children</keyword>
  <keyword>children (1-6 years) undergoing ambulatory orchipexy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

